Erik T. Engelson
Debkishore Mitra, Ph.D.
Daniel George has served as our Chief Financial Officer and Treasurer on a full-time basis since August 2020. From April 2019 until August 2020, Mr. George served as our Chief Financial Officer and Treasurer through his consulting practice, which he established in May 2016, specializing in providing executive financial services to healthcare companies covering a broad range of specialties. Mr. George served as Vice President, Finance for Avinger Inc., a publicly traded medical device company specializing in peripheral atherectomy from August 2014 to May 2016. From June 2012 to August 2014, Mr. George served as a consultant and Vice President of Finance for ApniCure, Inc., a medical device company specializing in the treatment of sleep apnea. From March 2009 to June 2012, Mr. George worked for Avantis Medical Systems, Inc., a manufacturer of colonoscopy visualization technology, where he was both a consultant and Chief Financial Officer. Mr. George was also the Sr. Director of Finance at FoxHollow Technologies Inc., a medical device company, and worked for PricewaterhouseCoopers LLP, an accounting and management consulting firm, in the assurance and business advisory practice. Mr. George holds B.S. degrees in both Accounting and Finance from California State University, Long Beach.
Tony Allen has served as our Chief Operations Officer since September 2021. From May 2018 to September 2021, Mr. Allen served as Vice President and Head of Global Internal Manufacturing at Ortho-Clinical Diagnostics, Inc., an in vitro diagnostics company. Mr. Allen served as Vice President and General Manager at Gap Partners, Inc., a metal fabrication company, from March 2017 to May 2018, Global Senior Project Management Office Head at Alcon Inc., an eye care device company, from March 2016 to March 2017 and Vice President of Operations at Accriva Diagnostics Holdings, Inc., a medical equipment and supplies manufacturing company, from October 2015 to March 2016. Prior to that he served in various operations and leadership roles at DJO Global, Inc., an orthopedic medical device company, for approximately eight years and at NEC Computers International, an information technology and electronics company, for approximately nine years. Mr. Allen received a T5 in telecommunications and radio communications from the Department of Marine Radio and Radar, Limerick, Ireland and an Executive M.B.A. from Aberdeen University.
Kevin Collins has served as our Chief Revenue Officer Since May 2021. Mr. Collins has over 15 years of commercial leadership experience in the medical technology industry. Prior to Joining Lucira, Mr. Collins served as Vice President of International Commercial Operations and Head of Sales and Market Development at Outset Medical. Prior to joining Outset, Kevin spent 12 years at Intuitive Surgical where he served as the Vice President for the Global Distribution business unit. Mr. Collins earned a B.A. in Communications and Political Science from the University of Arizona.
Ghazi Kashmolah has served as our Chief Quality Officer and Executive Vice President Regulatory Affairs since August 2021. Mr. Kashmolah has more than 30 years of experience in quality and regulatory work leading, developing and transforming global quality in the medical device and biotech industries. Most recently, he was Chief Quality Assurance, Regulatory Affairs, and EH&S Officer at Orchid Orthopedic Solutions. Prior to that, he led quality and regulatory affairs as SVP of QA/RA for DJO Global, VP of QA/RA at OSI Systems, and VP of Global QA/RA at Life Technologies. At Cardinal Health, Mr. Kashmolah was VP, Global Operations including manufacturing, supply chain, and quality. Mr. Kashmolah holds BS in electrical engineering from Wayne State University, an MS degree in electrical engineering from West Coast University, as well as an Executive MBA from University of Iowa Tippie School of Management.
Nadine Greiner, Ph.D. has served as our Chief Human Resources Officer since June, 2022. Nadine’s career has consisted of leading organizations through rapid growth and change. She has led the Human Resources function at private and public companies, and for capital ventures as well as for companies of over 15B in revenue. She has served as the head of Human Resources at the following: 4D Molecular Therapeutics, Sutter Health (California Pacific Medical Center and Palo Alto Medical Foundation), The Institute on Aging, Brown and Toland, Uplift Family Services, and globally in the Corporate Groups at Bank of America.
Nadine earned a dual doctorate in Organization Development and Clinical Psychology.
This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or revoked sooner.
These self-tests have been authorized by Health Canada under an Interim Order Authorization. The Lucira COVID-19 & Flu Test has been authorized only for the testing of nasal swabs from symptomatic individuals for the detection of nucleic acid from SARS-CoV-2, influenza A, and influenza B, not for any other viruses or pathogens. The Lucira COVID-19 Test has been authorized for testing of nasal swabs from individuals with or without symptoms for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.
To request more information contact us or call customer support at 1-888-582-4724
© 2022 Lucira Health, Inc. All rights reserved.
Canada
US
